Code | 4098B | ||||||||||
MA number | EU/1/15/991/003 | ||||||||||
Product Form: | plc ifc 6x200 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Merck Sharp & Dohme B.V., Netherland | ||||||||||
Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 23.03.2015 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 25.05.2021 |